To determine how broadly this adaptation extends, we screened the GLUT5 protein coding gene, SLC2A5, in datasets registered in the Genomics of Drug Sensitivity in Cancer (GDSC), Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) Portal. The gene discussed is SLC2A5; the disease is cancer.